DAY101 In Gliomas and Other Tumors
NCT03429803
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Low-grade Glioma
Interventions
DRUG:
DAY101
Sponsor
Karen D. Wright, MD
Collaborators
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]